Volume 30, Issue 140 (May & June 2022)                   J Adv Med Biomed Res 2022, 30(140): 295-298 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jameshorani M, Meydanloo M, Jafari S, Mansouri Hashchin S, Jafari M, Parsamanesh N. Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran. J Adv Med Biomed Res 2022; 30 (140) :295-298
URL: http://journal.zums.ac.ir/article-1-6372-en.html
1- Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
2- Dept. of Internal Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3- Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4- Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran , neginparsa.684@gmail.com
Abstract:   (84209 Views)

The 2019 Coronavirus disease pandemic (COVID-19) has spread to over two hundred countries worldwide, affecting > 170 million people and causing >3,500,000 deaths (May 29, 2021). Severe COVID-19 disease mostly disturbs the respiratory system, but gastrointestinal symptoms, including vomiting, nausea and diarrhea, are also present. Herein, we are reporting a COVID-19 patient with acute pancreatitis (AP) in Zanjan, Iran. . This patient showed acute pancreatitis as a COVID-19-related complication, emphasizing the importance of evaluating pancreas-specific plasma amylase levels in patients with COVID-19 and intestinal cramping.

Keywords: COVID-19, Pancreatitis, Iran
Full-Text [PDF 405 kb]   (41542 Downloads) |   |   Full-Text (HTML)  (1288 Views)  

 The 2019 Coronavirus disease pandemic (COVID-19) has spread to over two hundred countries worldwide, affecting > 170 million people and causing >3,500,000 deaths (May 29, 2021). Severe COVID-19 disease mostly disturbs the respiratory system, but gastrointestinal symptoms, including vomiting, nausea and diarrhea, are also present. Herein, we are reporting a COVID-19 patient with acute pancreatitis (AP) in Zanjan, Iran.


Type of Study: Case report | Subject: Clinical medicine
Received: 2021/01/14 | Accepted: 2021/06/24 | Published: 2022/04/1

References
1. Chinazzi M, Davis JT, Ajelli M, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395-400. [DOI:10.1126/science.aba9757] [PMID] [PMCID]
2. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773 [DOI:10.1016/S1473-3099(20)30195-X]
3. Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3,062 COVID‐19 patients: a meta‐analysis. J Med Virol. 2020; 92(10):1902-14 [DOI:10.1002/jmv.25884] [PMID] [PMCID]
4. Asghari A, Naseri M, Safari H, Saboory E, Parsamanesh N. The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options. DNA Cell Biol. 2020; 39(10):1741-53 [DOI:10.1089/dna.2020.5703] [PMID]
5. Nobel Y, Phipps M, Zucker J. Gastrointestinal symptoms and COVID-19: case-control study from the United States. Gastroenterology.2012; 159(1): 373-375.e2 [DOI:10.1053/j.gastro.2020.04.017] [PMID] [PMCID]
6. Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, Saboory E. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int J Neurosci. 2020:1-11. [DOI:10.1080/00207454.2020.1849193] [PMID]
7. Zhang Z, Zhang L, Zha D, Hu C, Wu X. Clinical characteristics and risks of Chinàs 2019 novel coronavirus patients with AKI: a systematic review and meta-analysis. Renal Failure. 2020;42(1):926-31. https://doi.org/10.1080/0886022X.2020.1796705 [DOI:10.1080/0886022X.2020.1812401]
8. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterol. 2020;158(6):1831-3. e3. [DOI:10.1053/j.gastro.2020.02.055] [PMID] [PMCID]
9. Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterol. 2020; 159(1):81-95 [DOI:10.1053/j.gastro.2020.03.065] [PMID] [PMCID]
10. D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management. Clin Gastroenterol Hepatol. 2020; 18(8):1663-72. [DOI:10.1016/j.cgh.2020.04.001] [PMID] [PMCID]
11. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterol. 2012;143(5):1179-87. e3. [DOI:10.1053/j.gastro.2012.08.002] [PMID] [PMCID]
12. Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID‐19; Virology, Biology and Novel Laboratory Diagnosis. J Gene Medicine. 2020:e3303. [DOI:10.1002/jgm.3303] [PMID] [PMCID]
13. Testoni PA. Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment. World J Gastroenterol. 2014;20(45):16891. [DOI:10.3748/wjg.v20.i45.16891] [PMID] [PMCID]
14. Hadi A, Werge MP, Kristiansen KT, et al. Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. Pancreatology. 2020; 20(4):665-67 [DOI:10.1016/j.pan.2020.04.021] [PMID] [PMCID]
15. Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta diabetologica. 2010;47(3):193-9. [DOI:10.1007/s00592-009-0109-4] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb